Senior consultancy in life science and technology

Aligning deep tech, biological, and data/AI development projects with a product vision tailored to market needs.

The new frontier

Organ-on-chip, ATMP, single-cell omics, brain probes, unique therapeutics delivery methods: current technological advancements are taking place in bioconvergence, at the intersection of deep tech, biology, and data.

The challenge?

  • Aligning deep tech, biological, and data/AI development projects with a product vision tailored to market needs, in order to obtain the best product-market fit.
  • Choosing the right technology valorization route and business models towards high long term value creation for company and shareholders.
  • Guiding multidisciplinary teams of scientists and engineers towards early-stage product or service development with market fit.
  • Engaging the right funding sources and venture capital.

"The exceptional thing about Katrien is that she uses her firm basis of knowledge to leverage the actual value creation of the starting technology company for which she is committed."

Dr. Ir. Paul Jacobs, co-founder PharmaFluidics

"Katrien was heavily involved in setting-up and negotiating the terms of multiple large commercial license agreements on the myNEO technology with biotechnology partners."

Cedric Bogaert, co-founder & CEO myNEO

"The feedback and learnings of the early market assessment Katrien completed are very well perceived by potential investors during fundraising."

Koen Huybrechts, Sr Venture Development Manager IMEC

"Katrien joined UgenTec from its early beginnings. Her experience in international sales and marketing, her network and diagnostic/biotech market knowledge are key to our company."

Wouter Uten, CEO UgenTec

Clients engage me...

...to overcome these challenges and to bridge the gap between these development trajectories and the market through senior consultancy in these domains:

  • Market intelligence studies
  • Venture track preparation
  • Technology valorization routes
  • Due diligence analysis
  • Entrepreneur in residence
  • Board representation

Why they do this?

I have worked in deep tech (IMEC, Axithra, PharmaFluidics), biological (ImmuneSpec, Milan, OHMX.bio), and data/AI projects (Ugentec, myNEO, MyCellHub), always with a focus on the go-to-market strategy.

With a background in biotech, an MBA and numerous business courses, and lots of relevant experience, I am well-prepared for the task.

This is also why I serve in these expert roles:

  • Expert-in-Residence at KU Leuven University
  • Expert business advisor at University of Antwerp

Interested? Let’s get in touch.

Call +32 476 85 38 76 or Send me an email.